The White House's AI adviser confirms that the Trump administration will not establish a regulatory body akin to the FDA for artificial intelligence, despite increasing public demand for oversight.
OpenAI's proposal to offer a five percent stake to the Trump administration underscores its intention to align closely with U.S. governance as it navigates the complex regulatory l...
The recent decision by the Trump administration to lift restrictions on Anthropic’s advanced AI models, Mythos and Fable, underscores the unpredictable nature of AI regulation in t...
In a recent episode of Equity, the discussion centered around the motivations behind the Trump administration's intensified scrutiny of Anthropic, a prominent player in the artific...
